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Abstract
Background
The human breast comprise several ductal systems, or lobes, which contain a small amount
of fluid containing cells, hormones, proteins and metabolites. The complex physiology of
these ducts is likely a contributing factor to the development of breast cancer, especially
given that the vast majority of breast cancers begin in a single lobular unit.
Methods
We examined the levels of total protein, progesterone, estradiol, estrone sulfate, dehydro-
epiandrosterone sulfate, and macrophages in ductal fluid samples obtained from 3 ducts
each in 78 women, sampled twice over a 6 month period. Samples were processed for both
cytological and molecular analysis. Intraclass correlation coefficients and mixed models
were utilized to identify significant data.
Results
We found that the levels of these ductal fluid components were generally uncorrelated
among ducts within a single breast and over time, suggesting that each lobe within the
breast has a distinct physiology. However, we also found that estradiol was more correlated
in women who were nulliparous or produced nipple aspirate fluid.
Conclusions
Our results provide evidence that the microenvironment of any given lobular unit is unique
to that individual unit, findings that may provide clues about the initiation and development
of ductal carcinomas.
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Introduction
The human breast contains several ductal systems, or lobes, which serve as conduits for breast
milk during lactation and are also the site of origin of the vast majority of breast cancers.
Knowledge of the anatomy and physiology of the ductal systems is fundamental for issues sur-
rounding normal mammary gland development and function as well as the diagnosis, treat-
ment, and prevention of breast cancer and other pathological breast conditions. Despite these
fundamental roles in lactation and disease, surprisingly little is known about human mammary
duct anatomy and physiology, especially in the non-lactating breast where most breast cancers
occur.
The majority of studies of human mammary duct anatomy have demonstrated that each
ductal system is comprised of ducts that open at the nipple through one of 5–9 orifices [1–6]
and branch into smaller and smaller passageways that ultimately terminate in lobules, where
milk is made during lactation. Investigations into the origins and development of breast cancer
in rodents have revealed that most breast cancers begin in the terminal ductal lobular units of
an individual duct, which consist of a small segment of duct and a cluster of lobules [7]. How-
ever, the number of ductal systems varies in any given human breast, as do basic features
within a particular ductal system such as morphology, size, and extent of branching [5, 8]. In
addition, other fundamental properties of the breast, such as whether the lobes are monoclonal
or polyclonal [9–11], or whether each lobe within a single breast contains the same composi-
tion and concentration of proteins, hormones, and other biomolecules, are strikingly underex-
plored. These properties could clearly affect the susceptibility of a specific lobe to cancer,
underscoring the notion that a better understanding of the anatomy and physiology of the
human breast could provide clues about cancer development.
Further evidence of the importance of focusing on the lobular unit rather than the breast is
that non-invasive disease such as ductal carcinoma in situ (DCIS) is usually localized to a single
ductal system [12]. Specific genetic and/or physiological factors within each lobe could predis-
pose or promote malignant transformation, while analogous factors in a neighbouring lobe
may support normal, healthy behaviour. To this point, the “theory of the sick lobe” posits that
DCIS and invasive breast cancer are diseases of the lobe in which genetic factors predispose the
duct to cancer, and environmental factors promote the development of the disease [13]. More-
over, Goldstein et al. have demonstrated that patients with high numbers of partially trans-
formed columnar cell lesions, collectively termed monomorphic epithelial proliferations, near
regions where cancerous tissue has been excised are more likely to have recurrences [14]. This
suggests that individual lobes may have large areas of premalignant cells that can ultimately
develop into cancer even after cancerous portions of the lobe have been removed.
The breast lobes contain a small amount of fluid that have numerous components, includ-
ing cellular constituents such as ductal epithelial cells, macrophages, and foam cells; serum pro-
teins such as albumin and immunoglobulins; hormones such as estrogens, androgens,
progesterone, dehydroepiandrosterone sulfate (DHEAS), and prolactin; growth factors such as
epidermal growth factor,transforming growth factor,and other biomolecules such as lipids,
cholesterol and lactose [15]. The role of hormones in breast cancer development has prompted
additional studies of hormone levels in ductal fluid [16–18], but the significance of the
observed varying hormone concentrations and their correlations with other components of the
ductal fluid is still poorly defined. Differing concentrations of these components could have
profound effects on the local environment in the breast, influencing whether the ductal cells
maintain a healthy disposition or progress toward a malignant phenotype. To this point, a key
question is whether the relative amounts of these components vary among lobes within a given
woman and vary over time within a single lobe.
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Two methods commonly used to access ductal fluid from the mammary ducts are nipple
aspiration and ductal lavage. Nipple aspiration involves massaging the breast, squeezing the
nipple and applying gentle suction through an aspirator to elicit fluid from the ductal orifices.
Whether or not a woman will express nipple aspirate fluid (NAF) depends on the woman as
well as the experience and methods used by the clinician collecting the fluid. NAF typically
emerges from just one or a few of the 5–9 ductal orifices on the nipple, and the properties of
NAF, such as color and viscosity, differ from lobe to lobe, suggesting physiological differences
among them. Because NAF or ductal fluid from a given subject is often pooled in studies, indi-
vidual characteristics of fluid from different ducts of the same breast or woman have not been
well characterized. An alternate method for sampling ductal fluid, called ductal lavage, enables
minimally invasive sampling of the content of individual ducts [19, 20]. The technique involves
local anesthetization of the nipple followed by duct dilation and cannulation. Saline (or another
biocompatible fluid) is instilled into the ductal system through the nipple and subsequently
recovered, bringing with it ductal epithelial cells and other components of the ductal fluid. This
technique enables repeat sampling of the interior of a single lobe and is thus an appealing
approach for investigating the physiology of individual lobes.
In this study, our primary goal was to evaluate the correlation between samples of ductal
fluid from different lobes within a single breast and within a given lobe sampled twice over 6
months using ductal lavage. We measured ductal fluid levels of total protein, macrophages, and
the hormones estrone sulfate, dehydroepiandrosterone sulfate (DHEAS), progesterone, and
estradiol. We assessed within-subject correlations among protein, macrophage, and hormone
levels and examined whether these ductal fluid components might be affected by individual
characteristics such as age, parity, menopausal status, and production of NAF. Our findings
have implications in understanding the physiology of the normal human mammary gland as
well as the etiology of breast diseases including cancer.
Materials and Methods
Subject recruitment
Seventy-eight women from a community setting with current non-suspicious mammograms
and unselected for risk were recruited to this study approved by the ethics committee and IRB
Independent Review Consulting, Inc. (IRC study # 05142). Recruitment took place through
local speaking engagements, news articles, and word of mouth. Exclusion criteria included cur-
rent pregnancy, lactation, chemotherapy, subareolar surgery, hormone use, and active breast
infection. The study design was explained and informed consent was obtained from all subjects
prior to their participation.
Sample collection
With a small number of noted exceptions, ductal lavage was performed by Dr. Susan Love for
the first 15 subjects and by Dr. Dixie Mills for the remaining 63 subjects. Prior to ductal lavage,
expression of NAF was attempted to identify which, if any, ducts were fluid-yielding, and this
information was recorded in the subject’s chart. Menopausal status was self-reported either by
lack of periods for 1 year or surgically. Additionally, no subject’s menopausal status changed
during the course of this study.
For the ductal lavage procedure, subjects received a 1 cubic centimeter (cc) injection of lido-
caine buffered with sodium bicarbonate (9:1 ratio) directly into the nipple using a tuberculin
syringe with a 30-gauge needle. Additional anesthetic was given throughout the procedure if
the subject regained sensitivity, and intranipple Marcaine (approximately 1 cc) was injected at
the end of the procedure to prolong the anesthetic effect. After the nipple was engorged with
Human Duct Physiology
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anesthetic, ductal orifices were more readily identifiable by dimpling of the skin or the presence
of fluid droplets. Upward traction on the nipple straightened the subareolar ducts increasing
the ease of cannulation.
Ductoscopy was performed in the standard manner with a 0.9-mm diameter, 10-cm long
microendoscope (Acueity, Hayward, CA) to document a ductal lumen or perforation. Regard-
less of whether a duct was observed to be intact or perforated, the ductoscope was removed and
replaced with a microcatheter (Cytyc, Marlborough, MA) that had been flushed with lidocaine
and standard ductal lavage was performed under ultrasound guidance. Lavage was performed
on 2 to 4 lobes in one breast under real-time monitoring with high-definition ultrasound (HDI
Philips 5000 SonoCt with Real-time Compound Imaging) equipped with a 5–12 MHz linear
array transducer. The double-lumen catheter tip was located and visualized on the monitor to
confirm its presence in an intact duct, and a total of 10 to 20 cc of saline was slowly instilled.
Approximately 5 to 10 cc of ductal fluid was retrieved for subsequent analysis.
A nipple grid was used to document the location of the lavaged ducts and a photo was taken
of a knotted suture in the ducts that had been lavaged. At a follow-up procedure 6 months
later, the same lobes were lavaged by the same surgeon who performed the initial procedure.
This allowed analysis of within-duct variability while minimizing potential variation due to cli-
nician performing the procedure. Lavaged lobes included both those that produced NAF (wet
lobes) and those that did not produce NAF (dry lobes).
Sample analysis
Ductal lavage samples were processed for both cytological and molecular analysis. Immediately
after collection, lavage effluent was centrifuged at 2500 rpm for 10 minutes to separate cells
from fluid components. Ductal lavage supernatant from each lobe was analyzed for total pro-
tein and hormone levels. Samples were analyzed at the University of California, Los Angeles
(UCLA) in the laboratory of Dr. Susanne Henning. Macrophage cell number for all samples
were analyzed in the laboratory of Dr. Jianyu Rao on Papanicolaou-stained slides prepared
from the cell pellet.
Chromatography mass spectrometry (GC-MS/MS) was used to analyze estradiol and pro-
gesterone in the ductal lavage samples. 17β-estradiol (Sigma, E-2758, St. Louis MO) and pro-
gesterone (E9145 Sigma), dissolved in methanol, was used to establish a standard curve.
Deuterated estradiol (17β-estradiol-d3, Sigma #491187) and progesterone-d9 (CDN Isotope
Inc. D-5385, Quebec Canada) were added as internal standard to 2–4.5 mL of ductal lavage
fluid samples prior to column concentration. Samples were extracted on a Supelco Discovery
solid phase extraction DPA-6S column (Supelco, Bellefonte, PA), pre-conditioned with ethyl
acetate, methanol, water and plasmalyte and eluted with ethyl acetate/methanol (4:1). 50 μL of
eluate was used for the progesterone analysis and directly injected into the GC/MS. The
remaining eluate was dried under nitrogen stream and redissolved in N,O-bis(trimethylsilyl)
trifluoroacetamide (BSTFA) with 1% trimethyl- chlorosilane (TMCS) catalyst (Supelco, Belle-
fonte PA,#3–3148) for derivatization at 65°C for 30 min. The derivatized samples were dried
under nitrogen stream and reconstituted with 50μL hexane. Analyses were carried out using a
ThermoQuest TRACETM 2000 gas chromatography coupled with a ThermoQuest TRACETM
MS. Sample injection (1 μL) was in splitless mode. A Restek RTx-5 column (15
m×0.25 μm×250 μm) GC column was used. Helium carrier gas was maintained at a constant
flow rate of 1.0 mL/min. The GC column temperature was programmed from 60 (initial equi-
librium time 2 min) to 280°C via a ramp of 10°C/min, 280–320°C via a ramp of 40°C/min and
maintained at 320°C for 3 min. The MS detection was by electron impact ionisation and oper-
ated in full scan mode for qualitative analysis or selected ion monitoring (SIM) mode for
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quantitative analysis. The limit of sensitivity was 8.8 pg/mL of progesterone and 0.1 pg/mL for
estradiol.
Estrone sulfate in 100 μL of lavage fluid was analysed using the radioimmunoassay from
Diagnostic Systems Laboratories (now Beckman Coulter) (Fullerton, CA) DSL5400 according
to manufacturer’s instructions. The DSL estrone sulfate radioimmunoassay uses a rabbit anti-
body preparation with high specificity for estrone sulfate. The procedure follows the basic prin-
ciple of radioimmunoassay where there is competition between a radioactive and a non-
radioactive antigen for a fixed number of antibody binding sites. The amount of [125I]-labeled
estrone sulfate bound to the antibody is inversely proportional to the concentration of unla-
beled estrone sulfate present. The separation of the free and bound antigen is achieved by using
a double antibody system. The intra-assay precision was 4.7, 4.6 and 9.2% for concentrations of
59.3, 9.0 and 0.35 ng/mL, respectively, and inter-assay precision was 5.5, 5.1 and 8.8 for con-
centrations of 11.3, 0.5 and 0.08 ng/mL of estronesulfate, respectively. The limit of sensitivity
was 0.456 pg/mL.
DHEAS in 10 μL of DLF was analyzed using the radioimmunoassay from Diagnostic Sys-
tems Laboratories (now Beckman Coulter) (Fullerton, CA) DSL3500. The intra-assay precision
was 6.3, 7.8 and 9.4% for concentrations of 37.4, 14.5 and 1.9 μg/dL of DHEAS, respectively,
and inter-assay precision was 9.9, 10 and 9.6 for concentrations of 55.5, 17.3 and 2.0 μg/dL of
DHEAS, respectively. The limit of sensitivity was 88 pg/mL.
Protein concentration was determined using the BioRad Protein Assay Dye Concentrate
(500–0006) and protein standard (BioRad 500–0007) according to the standard protocol.
For cytological analysis, the cells were resuspended in 20 mL of Preservcyt solution (Cytyc,
Marlborough, MA). Samples were submitted in a blinded fashion to a central laboratory and
were analyzed for macrophage on Papanicolaou-stained slides.
Statistical analysis
Given the relatively large proportion of analyte values below the detection limit (BDL, up to
half, depending on the analyte) a multiple imputation technique was used for analysis [21].
Specifically, ten data sets were created using clustered bootstrap sampling of the log-trans-
formed original data [22]. The maximum likelihood estimate of the mean of each analyte, by
visit, was calculated using spreadsheet software [23], and this was then used to derive the mean
of the truncated portion of the distribution below the BDL [24]. Under the assumption that
within-subject and within-duct correlation was the same for BDL values as for non-BDL val-
ues, analyte-specific BDL observations were imputed as follows: (1) using only non-BDL data,
the procedure MIXED in SAS v9.2 (SAS Institute, Inc., Cary, NC) was used in an unconditional
means model with “subject” and “duct” as random effects, (2) within-subject and within-duct
correlations were taken from the correlation matrix of the resulting estimated random effects
covariance (“V”) matrix (SAS/STAT v9.2 User’s Manual) [25], (3) a vector of 6 correlated
observations (corresponding to observations from 3 ducts over 2 visits) was randomly gener-
ated using the mean of the truncated distribution and the elements of the Cholesky decomposi-
tion of the V correlation matrix, (4) depending on the vector position of the BDL observation
relative to duct (first, second, or third duct within the given subject) and visit (first or second),
an imputed value was selected from the randomly generated vector to replace the BDL observa-
tion. All analyses involving analytes were based on combined estimates from the ten boot-
strapped data sets [26].
As a sensitivity analysis, BDL observations were also handled using three alternative meth-
ods: (1) excluding BDL observations from analysis (i.e., no assumptions about BDL correlation
structure but may induce bias due to the exclusion of data), (2) imputing BDL observations
Human Duct Physiology
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with random draws from a univariate distribution of values from 0 to the BDL value (i.e.,
assumes no correlation within BDL observations or between BDL and non-BDL observations),
and (3) imputing BDL observations with the midpoint value between 0 and the BDL value (i.e.,
assumes perfect correlation within BDL observations but no correlation between BDL and
non-BDL observations).
Within-lobe and within-subject correlations in observed analyte levels were evaluated by
calculating intraclass correlation coefficients (ICCs); specifically, within-lobe and within-sub-
ject ICCs were calculated as the ratio of the random effects covariance parameter estimate for
“lobe” and “subject,” respectively, to the sum of “lobe,” “subject,” and residual covariance
parameter estimates. Thus, the ICC represents the proportion of overall variability in analyte
levels attributable to the variability in analyte levels between lobes or subjects. For example, a
high within-subject ICC implies that a large amount of the variability observed in analyte levels
is due the variability that exists between individual subjects rather than within subjects, which
in turn implies that observations within subjects are highly correlated. An unstructured covari-
ance matrix was specified. Ninety-five percent confidence intervals for ICCs were computed as
the 2.5 and 97.5 percentiles of the ICC distribution resulting from 1000 trials of bootstrap-sam-
pling from each of the 10 bootstrapped data sets and computing the ICC as described above.
Differences in analyte levels by subject- and duct-level factors were analyzed using mixed
models. Relationships between pairs of analytes were evaluated by Pearson correlation coeffi-
cients. Covariance between analytes was not considered in the BDL imputation described
above; thus, reported correlations between pairs of analytes are conservative.
NAF was analyzed as an indicator variable both at the duct and subject level. Duct-level
NAF was defined as “yes” if the lobe produced NAF at either visit and as “no” otherwise. Sub-
ject-level NAF was defined as “yes” if any lobe at either visit produced NAF and as “no” other-
wise. Differences in macrophage levels by lobe- and subject-level NAF were tested using the
SAS procedure GENMOD with a binomial probability distribution and the logit link function.
Generalized estimating equations solutions were requested by declaring “subject” as a repeated
effect, with compound symmetry working correlation structures.
Results
Ductal lavage was performed on 206 ducts in 78 women, with the number of lobes per woman
ranging from 2 to 4. Most women (94%) contributed 3 ducts, and most ducts (79%) were sam-
pled twice, six months apart, for a total sample size of 419; of these, data were available for 397
(95%) ductal samples. Study participant characteristics are shown in Table 1. Mean age among
participants was 52 years; most had low breast cancer risk, were parous, and did not produce
NAF, and 44% were post-menopausal. Lobar characteristics are shown in Table 2. Among
lobes sampled from women who were not post-menopausal, there was a fairly even distribution
between follicular and luteal cycle at the time of lavage. Most lobeshad fewer than 10 macro-
phages and did not produce NAF. About 8% were perforated. Percentage of BDL ductal sam-
ples by analyte are shown in Table 3.
Ductal levels of total protein, estrone sulfate, DHEAS, and estradiol were similar between
visits (data not shown) but progesterone levels were lower at baseline than they were 6 months
later (mean (95% CI) log pg/mL progesterone = 1.97 (0.84, 3.09) at baseline, 3.01 (2.08, 3.94)
after 6 months; p = 0.053). Analyte levels did not differ by the participant-level factors of breast
cancer risk, parity, menopause status, or whether or not the participant produced NAF (data
not shown); however, differences in estradiol levels by age were borderline significant, with
younger women having higher estradiol levels than older women (mean (95% CI) log pg/mL
estradiol = -1.37 (-2.71, -0.02)< 45 years old, -2.81 (-4.04, -1.58)> 55 years old; p = 0.07).
Human Duct Physiology
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Analyte levels did not significantly differ by the lobe-level factors of anatomy (duct vs. perfora-
tion), cycle (follicular vs. luteal), NAF production, or number of macrophages, with the follow-
ing exceptions: lobes in the follicular phase had significantly lower protein levels than ducts in
Table 2. Duct Characteristics.
Parameter Duct Samples (N = 397)
Anatomy
Duct 290 (73.4)
Perforation 30 (7.6)
Unknown 75 (19.0)
Cycle
Follicular 79 (20.0)
Luteal 98 (24.8)
N/A 212 (53.7)
Unknown 6 (1.5)
NAF Producer
No 362 (91.6)
Yes 33 (8.4)
Macrophages
< 10 256 (64.8)
> = 10 48 (12.2)
Unknown 91 (23.0)
doi:10.1371/journal.pone.0150653.t002
Table 1. Study Participant Characteristics.
Parameter All Participants (N = 78)
Age (yrs)
N 78
Mean (SD) 51.7 (11.72)
Median 51.5
Interquartile range 44.0 -59.0
Range 22 -76
Breast cancer risk1 [n (%)]
Low 39 (50.0)
High 26 (33.3)
Breast cancer 9 (11.5)
Unknown 4 (5.1)
Nulliparous [n (%)]
No 49 (62.8)
Yes 29 (37.2)
Menopause status [n (%)]
Pre 44 (56.4)
Post 34 (43.6)
NAF Producer [n (%)]
No 62 (79.5)
Yes 16 (20.5)
1Based on Gail Index (High = Gail 1.66 or higher).
doi:10.1371/journal.pone.0150653.t001
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the luteal phase (mean (95% CI) log μg/mL protein = 0.99 (0.13, 1.84) follicular, 2.13 (1.38,
2.89) luteal; p = 0.03), and lobes with fewer macrophages had significantly lower protein levels
than ducts with more macrophages (mean (95% CI) log μg/mL protein = 1.26 (0.80, 1.73)< 10
macrophages, 2.99 (2.11, 3.87) 10 macrophages; p = 0.002). Differences in estrone sulfate
levels by cycle were borderline significant, with follicular ducts having lower estrone sulfate lev-
els than luteal ducts (mean (95% CI) log pg/mL estrone sulfate = -1.88 (-3.38, -0.39) follicular,
-0.53 (-1.82, 0.75) luteal; p = 0.08). Differences in progesterone levels by number of macro-
phages were borderline significant, with low-macrophage ducts having lower progesterone lev-
els than high-macrophage ducts (mean (95% CI) log pg/mL progesterone = 3.02 (2.07, 3.97)
low-macrophage, 4.48 (3.01, 5.96) high-macrophage; p = 0.06).
The largest degree of correlation, either positive or negative, between analytes was between
progesterone and estradiol (r = 0.23). Within-subject correlations among protein, progester-
one, estradiol, estrone sulfate, and DHEAS levels, both overall and stratified by participant-
level characteristics, are shown in Table 4. Overall ICCs ranged from 0.09 (95% CI = 0.04, 0.18)
for estrone sulfate to 0.24 (95% CI = 0.18, 0.35) for estradiol. The most notable ICC differences
by participant-level characteristics were that estradiol ICC was higher in nulliparous compared
Table 3. Percentage of Ductal Samples Below the Detection Limit.
Analyte Detection Limit N Number (%) Below the Detection Limit
Protein 0.1 μg/mL 397 51 (12.8)
Progesterone 8.8 pg/mL 394 137 (34.8)
Estradiol 0.1 pg/mL 394 205 (52.0)
Estrone sulfate 0.456 pg/mL 397 213 (53.7)
DHEAS 88 pg/mL 396 81 (20.5)
doi:10.1371/journal.pone.0150653.t003
Table 4. Intraclass Correlation Coefficients (ICCs) and 95%Confidence Intervals (CIs) by Analyte and Participant Characteristics.1
Participant Protein Progesterone Estradiol Estrone Sulfate DHEAS
Characteristic n ICC 95% CI n ICC 95% CI n ICC 95% CI n ICC 95% CI n ICC 95% CI
Overall 397 0.19 0.11, 0.32 394 0.17 0.12, 0.31 394 0.24 0.18, 0.35 397 0.09 0.04, 0.18 396 0.20 0.13, 0.30
Breast cancer risk
Higher 184 0.14 0.03, 0.25 183 0.11 0.04, 0.31 182 0.19 0.12, 0.36 184 0.04 0.00, 0.15 184 0.27 0.15, 0.41
Lower 190 0.23 0.08, 0.42 188 0.15 0.06, 0.32 190 0.29 0.16, 0.42 190 0.14 0.05, 0.27 189 0.15 0.03, 0.28
Nulliparous
No 240 0.23 0.11, 0.37 239 0.14 0.10, 0.32 239 0.12 0.06, 0.26 240 0.09 0.02, 0.20 240 0.24 0.15, 0.36
Yes 157 0.12 0.01, 0.33 155 0.23 0.08, 0.40 155 0.40 0.26, 0.56 157 0.09 0.01, 0.25 156 0.14 0.00, 0.28
Menopause status
Pre 211 0.16 0.03, 0.34 209 0.22 0.12, 0.38 210 0.29 0.18, 0.42 211 0.13 0.04, 0.25 210 0.14 0.06, 0.26
Post 186 0.23 0.12, 0.39 185 0.11 0.03, 0.31 184 0.15 0.09, 0.32 186 0.04 0.00, 0.16 186 0.26 0.15, 0.40
NAF producer
No 322 0.19 0.10, 0.31 319 0.14 0.08, 0.28 319 0.19 0.12, 0.31 322 0.07 0.02, 0.18 322 0.22 0.15, 0.33
Yes 75 0.22 0.00, 0.53 75 0.39 0.20, 0.66 75 0.47 0.24, 0.70 75 0.16 0.01, 0.33 74 0.13 0.00, 0.31
Macrophage levels
Low 244 0.10 0.00, 0.28 241 0.15 0.07, 0.31 241 0.27 0.16, 0.41 244 0.10 0.03, 0.24 243 0.21 0.13, 0.34
High 153 0.29 0.16, 0.42 153 0.17 0.07, 0.36 153 0.17 0.08, 0.32 153 0.08 0.00, 0.19 153 0.19 0.06, 0.34
1ICCs are means over 10 imputed data sets. 95% CIs are based on 2.5 and 97.5 percentiles of the ICC distribution over 1000 bootstrapped samples of
the 10 imputed data sets.
doi:10.1371/journal.pone.0150653.t004
Human Duct Physiology
PLOS ONE | DOI:10.1371/journal.pone.0150653 April 13, 2016 8 / 13
to parous women and in NAF producers compared to non-NAF producers, and progesterone
ICC was higher in NAF producers compared to non-NAF producers.
Within-subject ICCs by analytical method for dealing with BDL observations are shown in
Table 5. Predictably, ICC point estimates were most affected by method for the two analytes
with the highest percentage of BDL observations, estradiol and estrone sulfate, but overall there
was little effect of method on ICC point estimates.
For all analytes, correlation among analyte levels measured within the same lobe over two
visits was virtually zero (data not shown).
Macrophage levels by subject- and lobe-level NAF are shown in Table 6. Lavage fluid from
wet lobes had somewhat more macrophages than lavage fluid from dry lobes, though the differ-
ence was not significant (p = 0.67). Similarly, there was a non-significant greater number of
macrophages in ductal lavage fluid from women who produced NAF compared to those who
did not produce NAF (p = 0.33).
Discussion
Our examination of protein and certain steroid hormone levels in human mammary lobes sug-
gests that these components are generally not highly correlated within subjects, although there
Table 5. Intraclass Correlation Coefficients (ICCs) and 95%Confidence Intervals (CIs) by Analyte and Statistical Method to Account for Observa-
tions Below the Detection Limit (BDL).
Protein (13% BDL) Progesterone (35%
BDL)
Estradiol(52% BDL) Estrone Sulfate(54%
BDL)
DHEAS(21% BDL)
Method n ICC 95% CI n ICC 95% CI n ICC 95% CI n ICC 95% CI n ICC 95% CI
Multiple Imputation1 397 0.19 0.11, 0.32 394 0.17 0.12, 0.31 394 0.24 0.18, 0.35 397 0.09 0.04, 0.18 396 0.20 0.13, 0.30
Exclude2 346 0.21 0.05, 0.35 257 0.19 0.02, 0.42 189 0.29 0.11, 0.50 184 0.13 0.00, 0.39 315 0.22 0.08, 0.41
Random3 397 0.17 0.03, 0.37 394 0.17 0.04, 0.36 394 0.22 0.13, 0.41 397 0.07 0.00, 0.24 396 0.22 0.08, 0.36
Midpoint4 397 0.20 0.11, 0.30 394 0.17 0.11, 0.37 394 0.25 0.17, 0.42 397 0.09 0.03, 0.31 396 0.23 0.14, 0.33
1ICCs are means over 10 data sets with BDL values imputed. 95% CIs are based on 2.5 and 97.5 percentiles of the ICC distribution over 1000
bootstrapped samples of the 10 imputed data sets.
2BDL observations excluded.
3BDL observations imputed by random draw from a univariate distribution of values from 0 to BDL value.
4BDL observations imputed by midpoint value between 0 and BDL value.
doi:10.1371/journal.pone.0150653.t005
Table 6. Number of Macrophages by Duct- and Participant-Level NAF Status.
Duct NAF = No Duct NAF = Yes Participant NAF = No Participant
NAF = Yes
Number of (N = 383) (N = 36) (N = 339) (N = 80)
Macrophages n (%) n (%) n (%) n (%)
< 10 237 (85.3) 19 (73.1) 212 (85.5) 44 (78.6)
10–50 18 (6.5) 2 (7.7) 14 (5.6) 6 (10.7)
50–100 7 (2.5) 2 (7.7) 7 (2.8) 2 (3.6)
100–1000 9 (3.2) 2 (7.7) 9 (3.6) 2 (3.6)
> 1000 7 (2.5) 1 (3.8) 6 (2.4) 2 (3.6)
Unknown 105 10 91 24
Note: p-value for difference in number of macrophages = 0.67 by duct-level NAF and 0.33 by participant-level NAF.
doi:10.1371/journal.pone.0150653.t006
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may be differences in levels of certain hormones by factors that have been associated with
breast cancer risk, such as parity and NAF production. This finding has several far-reaching
ramifications for understanding the development and function of the normal mammary gland
and for efforts to determine the etiology and progression of breast disease, including breast
cancer. Lack of correlation among lobes intimates that the signaling and communication events
orchestrated by components of the ductal cells and fluid may be different in each duct, which
could result in individual duct differences in susceptibility to disease. These unique lobar char-
acteristics also gives more evidence that the breast lobes are individually different and lack a
significant number of anastomoses/connections. This theory is more in line with observations
from imaging studies like galactography, injections, and ductoscopy, and contrary to studies
that favour such anastomoses. Additionally, the fact that we observed that some hormones
were more correlated within nulliparous and NAF producing women may suggest that these
hormones may be the targets for future research on risk management, as these factors have pre-
viously been shown to be associated with increased breast cancer risk [27].
Other researchers have investigated within-subject correlation of biomarkers from ducts.
Chatterton et al. observed higher levels of correlation than we did; in their study, the variability
of estadiol, estrone sulfate, androstenedione, DHEA, DHEAS, and progesterone levels among
ducts within breasts averaged 51% less than that between women [28]. Participants in this
study were either breast cancer patients or were at high risk for breast cancer (GAIL> 1.6).
Interestingly, in our study, the highest within-breast correlations, albeit limited to estradiol,
were observed in nulliparous women and in women who produced NAF, factors that have
been associated with higher risk of breast cancer.Estradiol ICCs in our study were 0.40 in nul-
liparous women and 0.47 in NAF-producing women, while Chatterton et al. observed an ICC
of 0.33 for estradiol in their high-risk study population (the lowest ICC they observed among
all analytes).
Bhandare et al. also observed relatively high within-subject correlation for estradiol as well
as androstenedione, again in high-risk women [17]. However, they also determined that associ-
ations between certain biomarkers were stronger when the analyses were done within individ-
ual ducts than when done within a single woman. For example, in ductal lavage fluid, levels of
epidermal growth factor were significantly associated with estrone sulfate levels, and this asso-
ciation was more robust within a single duct than within an individual woman, suggesting
some independence between ducts.
Both the Chatterton and Bhandare studies differed methodologically from our study. For
example, in both of these studies, hormone levels were expressed per milligram of protein in
the fluid. This approach was used because, with the lavage procedure, the actual volume of duc-
tal fluid is not known because it is diluted by a large volume of buffer during the procedure [18,
27]; thus, expressing hormone levels relative to the amount of ductal fluid in the sample is not
possible. They theorized that, because the protein concentration in colostrum is relatively con-
stant, it is likely constant in lavage fluid as well, and in their analysis they demonstrated the
validity of this approach based on the correlations in their samples between hormone levels
expressed as per milliliter fluid and per milligram protein. This method assumes a constant
ratio of hormone to protein across protein levels. In our data, this was not the case, as the ratio
of hormone to protein decreased with increasing levels of protein. Because a relatively small
amount of ductal fluid is diluted to a much larger and relatively consistent volume, we felt it
was more appropriate to express hormone levels as milligrams per milliliter of lavage fluid.
Also, rather than exclude BDL data in our study, we explored alternative statistical methods
that allowed us to retain these data in our analyses. In both the Chatterton and Bhandere stud-
ies, samples with insufficient cells were excluded. These differences between our studies com-
plicate meaningful comparisons of our results.
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Chatterton et al. also measured changes in concentrations of various hormones and proteins
in NAF and ductal lavage fluid over time and found that levels were relatively stable within
individual lobes over 15 months, especially for estrone sulfate and DHEAS [18]. In contrast, we
observed very little correlation in hormone levels within individual ducts over a 6 month
period. Chatterton et al. also found that correlations were slightly higher within a single breast
over time than between the left and right breast at a single time, suggesting that local factors
may play a role in determining hormone and protein levels in NAF. However, since this study
did not compare levels of substances between ducts within a single breast at a given time, and
our study did not collect fluid from both breasts of the same woman, it is again difficult to
make direct comparisons between our findings.
Patil et al. examined epithelial cells in ductal lavage fluid in 65 high-risk women twice over a
six month period and found poor reproducibility of cell yield and cytology findings within the
same duct [29, 30]. The authors hypothesized that the higher proportion of lower cell yield
from the second visit suggests that ductal lavage may have stripped the epithelium and/or
weakened the duct walls, compromising the integrity of the second sampling. In addition, they
suggest that the poor cytological reproducibility observed indicates that ductal lavage may not
be an optimal method for serial evaluation of the ductal epithelium. The fact that we did not
observe decreased mean hormone and total protein levels over the 6-month period of our
study suggests that if the lavage procedure does cause prolonged epithelial stripping, this does
not lead to a systematic decline in hormone and protein levels in ductal fluid. We hypothesize
that variability in the ductal fluid is due to an inherent dynamic and variable physiology in the
ducts.
Our finding that women who produced NAF had somewhat higher numbers of macro-
phages in their ducts is intriguing given the links between inflammation, the immune system,
and cancer [31, 32]. Though the physiology of NAF is not well understood, there is some evi-
dence that women who produce NAF are at increased risk for breast cancer [33, 34]. The possi-
ble contribution of macrophages to this complex physiology is unclear, but our data provide
another potential piece to the multifaceted puzzle of factors that contribute to breast cancer
development.
There were limitations to our study. A relatively large proportion of data were BDL. While
we used several different statistical approaches to incorporating these data into our analysis
and observed consistent ICCs regardless of method, the correlation structure of these data are
unknown and the assumptions required by these various statistical methods may not be biolog-
ically correct. As mentioned previously, it is not possible to measure the actual volume of duc-
tal fluid from the lavage process, which complicates standardization. We chose to not
standardize analyte levels and instead used actual measured amounts of total protein and each
hormone in a given sample, which assumes that each sample contained the same amount of
fluid. It is not possible to quantify the effect this may have had on our findings.
On the other hand, a strength of our study was the demonstration that majority of the ducts
were able to be sampled twice without a drop in yield, demonstrating further data that follow
up within the same duct is feasible. This finding also highlights the potential of an intraductal
approach for evaluation of breast health [34–36]. Intraductal methods such as ductal lavage
and ductoscopy offer a means to access, evaluate, and even treat individual mammary ducts.
The local nature of non-invasive breast cancer and other breast conditions such as papillomas,
coupled with our evidence that duct physiology may differ from duct to duct, espouses the idea
that intraductal methods can be more effective for managing breast conditions than many of
the invasive, surgical or systemic options in current use.
In summary, our study demonstrated that the hormonal and cellular environment of indi-
vidual ducts within the same woman and within the same duct over time is variable. Individual
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ducts likely require individual attention, and further investigation of these distinct ducts could
be the key in identifying the origins of breast tumorigenesis, giving a target for a potential cure.
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